SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. is trending following the White House's announcement of new executive orders focused on quantum sensing and networking, which positions the company as a key beneficiary in the quantum sector. Investors are actively discussing the stock's long-term potential, its upcoming Russell 3000 inclusion, and the impact of government-backed quantum initiatives on the broader technology landscape.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense selling pressure, with the stock sliding toward 52-week lows amid a broader cooling of software sector valuations. Investors are actively debating whether this is a structural breakdown or a temporary sentiment reset, with many highlighting the tension between the company's strong revenue growth and concerns over its high valuation multiples.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors debate the impact of leadership changes, including the upcoming departure of the CFO, while closely monitoring progress in the company's oncology pipeline following recent trial updates. Market participants are actively discussing the stock's long-term valuation and the effectiveness of current growth strategies in the competitive biotech landscape.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant investor interest as shareholders bet on a long-term turnaround fueled by international expansion, a new CEO, and persistent buyout speculation involving major stakeholders. The community remains heavily focused on the stock's elevated short interest, with many retail traders actively discussing the potential for a short squeeze despite ongoing concerns regarding operational efficiency and food quality.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to the company's roadmap for gate-model quantum simulators and potential expansion into government-backed quantum initiatives. The community remains highly polarized, with intense debate between long-term bulls betting on quantum supremacy and skeptics focused on high cash burn, heavy insider selling, and extreme valuation concerns.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics (DFTX) is experiencing heightened investor interest driven by positive Phase 3 data for its MDD therapeutic and anticipation of a series of upcoming pivotal trial milestones. The community is actively debating the company's long-term commercialization prospects and the impact of a recent major public offering, with many investors weighing the potential for a breakthrough against the risks of dilution and the competitive landscape for psychedelic-based medicine.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is seeing intense investor attention and increased trade volume following a significant purchase order for its NeuraWave photonic reservoir systems and broader sector momentum surrounding government-led quantum technology initiatives. The community remains highly focused on the company's hardware commercialization progress and the potential for a short squeeze, given the substantial short interest and heavy call option activity.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting significant retail and institutional interest as investors track substantial share accumulation by CEO Kevin Tang and speculate on a potential buyout. While the company maintains clinical progress and steady commercial performance, the community remains divided, weighing the upside of recent insider activity against long-standing frustration over management transparency and sluggish price movement.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum Holdings is seeing heightened interest due to its focus on software infrastructure and strategic partnerships with major quantum hardware players, leading the community to discuss its potential as a long-term play in the evolving quantum sector. Traders are actively tracking the stock's low float and recent volatility, weighing the impact of institutional backing against concerns regarding its patent moat and market valuations.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is generating significant momentum as investors pivot from viewing it as a simple telehealth app to an emerging infrastructure platform, with sentiment bolstered by a high-profile medical officer hire and anticipated regulatory updates regarding compounded peptides. While some traders are capitalizing on high-volatility swings and bullish sentiment around long-term growth, others remain cautious of technical resistance levels and potential volatility surrounding upcoming advisory meetings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trump Provides Fresh Boost To Quantum Computing Space, Signs Two Orders - IBM, INFQ, QBTS, RGTI, QUBT Stocks In Focus

Equity

President Donald Trump issued two executive orders aimed at accelerating public-private development of a scientifically functional quantum computer by 2028.

IBM (IBM) Gains As Market Dips: What You Should Know

In the closing of the recent trading day, IBM (IBM) stood at $252.22, denoting a +1.25% move from the preceding trading day.

IBM and OpenAI Bring Frontier AI to Cyber Defense--Helping Enterprises Keep Pace with Machine-Speed Threats

IBM and OpenAI Bring Frontier AI to Cyber Defense--Helping Enterprises Keep Pace with Machine-Speed Threats IBM and OpenAI Bring Frontier AI to Cyber Defense--Helping Enterprises Keep Pace with Machine-Speed Threats PR Newswire ARMONK, N.Y., June 22, 2026 ARMONK, N.Y., June 22, 2026 /PRNewswire...

Can IBM's New AI Features for Wimbledon 2026 Redefine Fan Experience? 

IBM's new AI-powered Wimbledon 2026 features aim to make matches more interactive, personalized and easier for fans to follow in real time.

Prediction: These 16 Words From IBM Will Prove to Be Prophetic About Artificial Intelligence's Future

Key PointsAI agents can potentially end up taking over many common day-to-day tasks that humans do today...

Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026

Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026 Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026 PR Newswire WIMBLEDON, June 22, 2026 WIMBLEDON, June 22, 2026...

Notable Thursday Option Activity: IBM, AXP, VRT

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in International Business Machines Corp (Symbol: IBM), where a total volume of 61,834 contracts has been traded thus far today, a contract volume which is representa...

Why Is IBM Stock Declining On Thursday?

International Business Machines Corp. (NYSE: IBM) stock faces downward pressure on Thursday after sector peer Accenture narrows its fiscal 2026 sales guidance.read more...

How Could Federal Backing Advance D-Wave's Quantum Efforts?

QBTS signs a $100M LOI under the CHIPS and Science Act, signaling federal backing that could accelerate its quantum computing R&D and qubit roadmap.

Amazon AI exec predicts first 'commercially useful' quantum computers in 5-7 years

Quantum computing is becoming an increasingly competitive field with tech giants like Microsoft, Google and IBM developing the technology...

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Traders are closely watching executive orders on post-quantum cryptography, viewing the tech as a major long-term catalyst.

A recent White House visit and supportive remarks from the President have sparked intense speculation of a sustained pump.

Bulls are aggressively defending the stock, arguing it is significantly undervalued compared to its potential AI and infrastructure utility.

Debates persist over whether this stock will experience a rally similar to past moves seen in other high-growth tech tickers.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$3.01	--	--	N/A
Q1 '26	$1.81	$1.91	5.57%	BEAT
Q4 '25	$4.31	$4.52	4.91%	BEAT
Q3 '25	$2.45	$2.65	8.32%	BEAT
Q2 '25	$2.65	$2.80	5.70%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

IBMInternational Business Machines Corp.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest IBM News